Mates Sharon bought BNTC
November 5, 2025 · Form 4 insider transaction
Mates Sharon bought 28,517 shares of Benitec Biopharma Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
28,517
Price
$0.00
Total value
N/A
InsiderMates Sharon
RoleDirector
SecurityOptions (right to buy)
Transaction codeA: Grant or award
Transaction dateNovember 5, 2025
Filing dateNovember 7, 2025
Shares owned after28,517
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Options will vest in full on the earlier of immediately prior to the Issuer's 2026 annual meeting of stockholders and November 5, 2026.